Circassia Group PLC
LSE:CIR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sunshine Insurance Group Co Ltd
HKEX:6963
|
CN |
|
Fumakilla Ltd
TSE:4998
|
JP |
|
N
|
Ninety One Ltd
JSE:NY1
|
ZA |
|
B
|
Brockman Mining Ltd
HKEX:159
|
HK |
|
A
|
Axyz Co Ltd
TSE:1381
|
JP |
|
H
|
Huawen Media Group
SZSE:000793
|
CN |
|
Doyen International Holdings Ltd
HKEX:668
|
HK |
Circassia Group PLC
Inventory
Circassia Group PLC
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Circassia Group PLC
LSE:CIR
|
Inventory
£4.1m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Inventory
£6.7m
|
CAGR 3-Years
96%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Compass Pathways PLC
NASDAQ:CMPS
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Inventory
£74.2m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
16%
|
CAGR 10-Years
8%
|
|
|
Oxford BioMedica PLC
LSE:OXB
|
Inventory
£17.3m
|
CAGR 3-Years
11%
|
CAGR 5-Years
20%
|
CAGR 10-Years
20%
|
|
Circassia Group PLC
Glance View
Circassia Group Plc is a holding company, which engages in the development and commercialization of respiratory products. The company is headquartered in Oxford, Oxfordshire and currently employs 128 full-time employees. The company went IPO on 2014-03-13. The firm operates through two segments: NIOX and COPD. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). The COPD segment relates to the Tudorza and Duaklir Pressair products marketed in the United States, where they are indicated for the maintenance treatment of patients with COPD. Its NIOX FeNO measurement and monitoring products are used by physicians around the world to help improve asthma diagnosis and management. Its FeNO diagnosis and management products helps healthcare to professionals manage their patient's asthma. Its NIOX VERO is a non-invasive, point-of-care system that provides FeNO measurements. The firm provides products and services in around 50 countries.
See Also
What is Circassia Group PLC's Inventory?
Inventory
4.1m
GBP
Based on the financial report for Dec 31, 2022, Circassia Group PLC's Inventory amounts to 4.1m GBP.
What is Circassia Group PLC's Inventory growth rate?
Inventory CAGR 5Y
-4%
Over the last year, the Inventory growth was 52%. The average annual Inventory growth rates for Circassia Group PLC have been -14% over the past three years , -4% over the past five years .
